|
COPYRIGHT 2004 Investor's Business Daily, Inc.
MEDICAL
Icahn buyout bid ups Mylan fight
Financier Carl Icahn said he was willing to pay $20 a share, or $5 bil, for the generic drug maker, significantly raising the stakes in his bid to derail Mylan Lab's proposed $3.37 bil buyout of King Pharma. Icahn, who owns 9.8%...
Read the full article for free courtesy of your local library.
|